Economists warn of costs if Medicare covers new obesity drugs

Posted on AllSides March 11th, 2023
From The Center
REUTERS/Mike Blake

The cost of expanding U.S. Medicare prescription drug coverage to pay for expensive, new obesity medications could be catastrophic, health economists warned in a report published on Saturday.

Big-selling diabetes drugs have been repurposed as obesity treatments after demonstrating weight loss of more than 20% in clinical trials. While they are far more effective than older drugs, lifetime use might be required to keep lost weight off.

Once-weekly injections of Novo Nordisk's (NOVOb.CO) Wegovy, for example, cost more than $13,000 per year in the U.S. after rebates and discounts. Mounjaro from Eli...

Read full story

AllSides Picks

https://www.reuters.com/world/us/economists-warn-costs-if-us-medicare-covers-new-obesity-drugs-2023-03-11/

More News about Healthcare from the Left, Center and Right

From the Left

From the Center

From the Right